These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33448714)

  • 21. Contraception-related venous thromboembolism in a pediatric institution.
    Pillai P; Bonny AE; O'Brien SH
    J Pediatr Adolesc Gynecol; 2013 Jun; 26(3):186-8. PubMed ID: 23566795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity in adolescent men increases the risk of venous thromboembolism in adult life.
    Glise Sandblad K; Jern S; Åberg M; Robertson J; Torén K; Lindgren M; Adiels M; Hansson PO; Rosengren A
    J Intern Med; 2020 Jun; 287(6):734-745. PubMed ID: 32338406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J; Gompel A; Plu-Bureau G
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.
    Larivée N; Suissa S; Coulombe J; Tagalakis V; Filion KB
    Drug Saf; 2017 Jul; 40(7):583-596. PubMed ID: 28382493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral Contraceptive Types in Relation to ABO Blood Groups Among Saudi Women of Different Reproductive Age Groups and Impact on Venous Thromboembolism.
    Mohamed ABO; Al-Ama N; Al Kreathy H; Ahmed KHB; Al Amri T; Harakeh S; Mousa SA; De Laat B
    Clin Appl Thromb Hemost; 2020; 26():1076029620966051. PubMed ID: 33112684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboembolism as the adverse event of combined oral contraceptives in Japan.
    Sugiura K; Kobayashi T; Ojima T
    Thromb Res; 2015 Dec; 136(6):1110-5. PubMed ID: 26475406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study.
    Martinelli I; Maino A; Abbattista M; Bucciarelli P; Passamonti SM; Artoni A; Gianniello F; Peyvandi F
    Thromb Res; 2016 May; 141():153-7. PubMed ID: 27043069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venous thromboembolism in young female while on oral contraceptives: high frequency of inherited thrombophilia and analysis of thrombotic events in 400 czech women.
    Dulícek P; Malý J; Pecka M; Beránek M; Cermáková E; Malý R
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):567-73. PubMed ID: 19117968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.
    Rintelen C; Mannhalter C; Ireland H; Lane DA; Knöbl P; Lechner K; Pabinger I
    Br J Haematol; 1996 May; 93(2):487-90. PubMed ID: 8639453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies.
    Larivée N; Suissa S; Khosrow-Khavar F; Tagalakis V; Filion KB
    BJOG; 2017 Sep; 124(10):1490-1499. PubMed ID: 28276140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study.
    Farmer RD; Todd JC; Lewis MA; MacRae KD; Williams TJ
    Contraception; 1998 Feb; 57(2):67-70. PubMed ID: 9589831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity and contraceptive use: impact on cardiovascular risk.
    Rosano GMC; Rodriguez-Martinez MA; Spoletini I; Regidor PA
    ESC Heart Fail; 2022 Dec; 9(6):3761-3767. PubMed ID: 36103980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oral contraceptive pill and thrombotic risk: epidemiological studies].
    Fruzzetti F; Perini D; Spirito N; Manca R
    Minerva Ginecol; 2012 Dec; 64(6):539-49. PubMed ID: 23232538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.
    Suchon P; Al Frouh F; Henneuse A; Ibrahim M; Brunet D; Barthet MC; Aillaud MF; Venton G; Alessi MC; Trégouët DA; Morange PE
    Thromb Haemost; 2016 Jan; 115(1):135-42. PubMed ID: 26290123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral contraceptives and the risk of venous thromboembolism.
    Middeldorp S
    Gend Med; 2005; 2 Suppl A():S3-9. PubMed ID: 16551555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Albumin, oral contraceptives, and venous thromboembolism risk in astronauts.
    Zwart SR; Auñón-Chancellor SM; Heer M; Melin MM; Smith SM
    J Appl Physiol (1985); 2022 May; 132(5):1232-1239. PubMed ID: 35389755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epidemiological characteristics of thromboembolism related to oral contraceptives in Japan: Results of a national survey.
    Sugiura K; Kobayashi T; Ojima T
    J Obstet Gynaecol Res; 2021 Jan; 47(1):198-207. PubMed ID: 32885566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
    Suissa S; Blais L; Spitzer WO; Cusson J; Lewis M; Heinemann L
    Contraception; 1997 Sep; 56(3):141-6. PubMed ID: 9347203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills.
    Committee on Gynecologic Practice
    Obstet Gynecol; 2012 Nov; 120(5):1239-42. PubMed ID: 23090561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Venous thromboembolism and combined oral contraceptives. Reported adverse reactions indicate at least similar risk with the most recent contraceptive pills].
    Kieler H; Persson I; Odlind V
    Lakartidningen; 2003 Sep; 100(39):3050-2. PubMed ID: 14560670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.